6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers
Status:
Completed
Trial end date:
2020-01-02
Target enrollment:
Participant gender:
Summary
A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the
Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in
Healthy Volunteers